Projects per year
Fingerprint
Dive into the research topics where Michael (Mike) Powers is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
-
-
-
GROWTH FACTORS IN NEONATAL HYPEROXIC EYE AND LUNG INJURY
Powers, M. (. & Tomarev, S.
8/1/91 → 7/31/96
Project: Research project
-
avorable Clinician Acceptability of Telehealth as Part of the Cystic Fibrosis Care Model during the COVID-19 Pandemic
Perkins, R. C., Davis, J., NeSmith, A., Bailey, J., Powers, M. R., Chaudary, N., Siracusa, C., Uluer, A., Solomon, G. M. & Sawicki, G. S., Sep 2021, In: Annals of the American Thoracic Society. 18, 9, p. 1588-1592 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access4 Scopus citations -
Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study
VX14-661-110 study group, Jul 2021, In: The Lancet Respiratory Medicine. 9, 7, p. 733-746 14 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Patient and family perceptions of telehealth as part of the cystic fibrosis care model during COVID-19
Jaclyn, D., Andrew, N. S., Ryan, P., Julianna, B., Christopher, S., Nauman, C., Powers, M., Gregory S, S. & George M, S., May 2021, In: Journal of Cystic Fibrosis. 20, 3, p. e23-e28Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Changes in lung clearance index in preschool-aged patients with cystic fibrosis treated with ivacaftor (GOAL): A clinical trial
Ratjen, F., Klingel, M., Black, P., Powers, M. R., Grasemann, H., Solomon, M., Sagel, S. D., Donaldson, S. H., Rowe, S. M. & Rosenfeld, M., Aug 15 2018, In: American journal of respiratory and critical care medicine. 198, 4, p. 526-528 3 p.Research output: Contribution to journal › Letter › peer-review
22 Scopus citations -
Effects of diagnosis by newborn screening for cystic fibrosis on weight and length in the first year of life
Baby Observational and Nutrition Study (BONUS) Investigators of the Cystic Fibrosis Foundation Therapeutics Development Network, Jun 2017, In: JAMA Pediatrics. 171, 6, p. 546-554 9 p.Research output: Contribution to journal › Article › peer-review
51 Scopus citations